Menu
Surgical Intervention
Major Operative Suite
Major Operative Suite Invasive Expected Stay: 8 Days

Orthotopic Neobladder Reconstruction

Protocol / Details

Orthotopic neobladder reconstruction is a complex urinary diversion procedure performed following radical cystectomy for bladder cancer. The technique involves the isolation of a 40-60 cm segment of the ileum, which is detubularized and reconfigured into a spherical reservoir (neobladder). The ureters are anastomosed to the proximal end of the pouch, and the distal end is anastomosed to the urethral stump. The procedure requires advanced surgical expertise to ensure proper configuration, adequate capacity, and continence.

Procedure Type
Surgery / Invasive
Estimated Base Cost
Varies by patient
Medical & Surgical Disclaimer The clinical information provided regarding this procedure is for educational purposes only. Only a qualified specialist or surgeon can determine if you are a suitable candidate for this intervention after a thorough examination.

Mandibular fasting for 8 hours, mechanical bowel preparation, prophylactic intravenous antibiotics, thromboembolism prophylaxis (TED stockings and heparin), electrolyte balancing, and informed consent for complex urological reconstruction.

Strict intake/output monitoring, immediate irrigation of the neobladder catheter, early mobilization, parenteral to enteral nutrition transition, and pelvic floor muscle training. Discharge typically follows the stabilization of metabolic parameters and demonstration of patient competence in self-catheterization.

Comprehensive Clinical Guide: Orthotopic Neobladder Reconstruction

Orthotopic neobladder reconstruction represents the gold standard in urinary diversion following a radical cystectomy. For patients facing invasive bladder cancer, the psychological and physical burden of a permanent stoma can be significant. The orthotopic neobladder offers a sophisticated alternative, restoring the ability to void via the urethra, thereby preserving body image and quality of life.


1. Introduction & Overview

Orthotopic neobladder reconstruction is a complex reconstructive urological procedure where a segment of the patient’s own bowel—typically the ileum—is reconfigured into a spherical reservoir (neobladder) and anastomosed to the urethra. This procedure allows for continent, orthotopic urinary diversion, meaning the patient can void through the natural urethral meatus.

The primary objective is to replicate the physiological function of the native bladder: maintaining low-pressure storage, providing adequate capacity, and facilitating social continence while preserving upper urinary tract integrity.


2. Technical Specifications & Mechanisms

The procedure relies on the principles of detubularization and spherical configuration to achieve the "Law of Laplace" benefits, which dictate that increasing the radius of a spherical container reduces wall tension and internal pressure.

The Surgical Mechanism

  1. Detubularization: The selected bowel segment is opened along the antimesenteric border. This disrupts the coordinated peristaltic contractions of the bowel, transforming high-pressure, rhythmic contractions into a low-pressure reservoir.
  2. Configuration: The detubularized segment is folded into a "U," "W," or "Studer" shape to create a spherical pouch.
  3. Anastomosis: The reservoir is attached to the urethral stump (orthotopic) and the ureters are reimplanted into the neobladder using a reflux-preventing technique (e.g., Le Duc or Wallace anastomosis).
Feature Specification
Bowel Segment Typically 40–60 cm of terminal ileum
Pressure Profile Low-pressure, high-compliance reservoir
Voiding Mechanism Abdominal straining and Valsalva maneuver
Capacity 400–600 mL post-maturation

3. Clinical Indications & Usage

Not every patient is a candidate for a neobladder. Patient selection is critical to ensure success.

Primary Indications

  • Muscle-Invasive Bladder Cancer (MIBC): T2-T4a, N0, M0.
  • High-Risk Non-Muscle-Invasive Bladder Cancer: Recurrent, BCG-refractory disease where cystectomy is indicated.
  • Bladder-Sparing Failure: Patients who failed radiation therapy or trimodal therapy.

Selection Criteria

  • Adequate Urethral Margin: The urethral margin must be negative for malignancy on frozen section biopsy.
  • Renal Function: Adequate GFR is required to handle the metabolic load of bowel reabsorption.
  • Cognitive/Physical Ability: The patient must be capable of performing intermittent catheterization if urinary retention occurs.
  • Motivation: The patient must be committed to a structured post-operative physical therapy and voiding schedule.

4. Pre-Operative Preparation

Preparation is multi-disciplinary, involving the surgeon, anesthesia, and stoma therapy nursing.

  • Nutritional Optimization: High-protein intake and correction of anemia.
  • Bowel Preparation: Mechanical bowel prep (e.g., polyethylene glycol) and prophylactic antibiotics.
  • Counseling: Extensive discussion regarding the necessity of learning new voiding techniques (Valsalva) and the potential for long-term complications.
  • Stoma Site Marking: Even if a neobladder is planned, a "backup" stoma site is marked in case the surgeon discovers intra-operative findings that make a neobladder impossible (e.g., extensive urethral involvement).

5. The Procedure: Step-by-Step

Phase I: Radical Cystectomy

The bladder, prostate (in men), and seminal vesicles are removed. In women, the bladder, uterus, ovaries, and anterior vaginal wall are typically resected. The urethra is preserved, and the urethral margin is biopsied.

Phase II: Bowel Harvesting

A 40–60 cm segment of ileum is isolated, keeping the mesenteric blood supply intact. Bowel continuity is restored via an ileo-ileal anastomosis.

Phase III: Neobladder Construction

  • The isolated segment is detubularized.
  • The posterior wall is sutured.
  • Ureteric anastomoses are performed.
  • The anterior wall is closed, leaving an opening for the urethral anastomosis.

Phase IV: Urethral Anastomosis

The neobladder is brought down into the pelvis and sutured to the urethral stump over a large-bore catheter.


6. Post-Operative Recovery & Protocol

Recovery is a marathon, not a sprint. Patients typically remain in the hospital for 5–10 days.

  1. Immediate Post-Op: Strict fluid balance, management of the urethral catheter, and early mobilization to prevent ileus.
  2. Catheter Management: The urethral catheter remains in place for 2–3 weeks. A pouchogram is performed to check for leaks before removal.
  3. Continence Training: Once the catheter is removed, patients begin "timed voiding" every 2–3 hours, gradually increasing the interval as the bladder capacity increases.
  4. Pelvic Floor Physiotherapy: Essential for strengthening the external urinary sphincter.

7. Potential Complications

Category Complication
Early Ileus, urine leak, pelvic abscess, DVT/PE
Late Urinary retention, hyperchloremic metabolic acidosis, B12 deficiency, stone formation
Functional Nighttime incontinence (nocturia), daytime incontinence
  • Hyperchloremic Metabolic Acidosis: Occurs because the bowel absorbs ammonium and chloride from the urine. Long-term oral bicarbonate supplementation is often required.
  • Vitamin B12 Deficiency: If the terminal ileum is harvested, long-term B12 monitoring is mandatory.

8. Alternative Treatments

  • Ileal Conduit: The most common alternative. A permanent stoma with an external bag. Easier to perform and fewer complications, but impacts body image.
  • Continent Cutaneous Reservoir (Indiana Pouch): A reservoir created from the colon/ileum, but drained via a stoma on the abdomen using a catheter. Used if the urethra cannot be saved.

9. Massive FAQ Section

1. Will I be "cured" of bladder cancer?

Orthotopic neobladder is a diversion method, not a cancer treatment. Success depends on the stage of your cancer and successful completion of adjuvant treatments if needed.

2. Will I void normally?

You will void through your urethra, but the process is different. You will not have a "urge" to void like a normal bladder. You must void by the clock and use abdominal pressure (Valsalva) to empty the reservoir.

3. How long does the surgery take?

Typically 5 to 8 hours, depending on the complexity of the cystectomy and reconstruction.

4. What is the success rate for continence?

Daytime continence is achieved in 85–90% of patients. Nighttime continence is more challenging and is achieved in about 70–80% of patients.

5. Can I get a urinary tract infection (UTI)?

Yes. Bacteria colonize the neobladder easily. However, you should only treat with antibiotics if you have symptoms like fever, flank pain, or cloudy/foul-smelling urine.

6. Do I need to perform intermittent catheterization?

Some patients experience "neobladder outlet obstruction" or incomplete emptying. If you cannot empty your bladder, you must learn to perform clean intermittent self-catheterization (CISC).

7. Will I have to take medication long-term?

Many patients require sodium bicarbonate to prevent metabolic acidosis. Periodic B12 injections may also be necessary.

8. What happens to my sexual function?

Nerve-sparing techniques can be used, but sexual function is often impaired due to the proximity of the bladder to the pelvic nerves. Discuss "nerve-sparing cystectomy" with your surgeon.

9. How often do I need follow-up?

Regular surveillance is critical. This includes blood work (electrolytes, renal function, B12) and imaging/cystoscopy to monitor for cancer recurrence.

10. Is the neobladder permanent?

Yes, it is designed for the remainder of your life. However, if major complications arise, it can be converted to an ileal conduit.


10. Conclusion

Orthotopic neobladder reconstruction is a transformative procedure that allows patients to maintain a high quality of life despite the diagnosis of bladder cancer. While the surgical complexity and the requirement for active post-operative participation are high, the reward—the restoration of natural voiding—remains a pinnacle of modern reconstructive urology. Patients must be carefully selected, thoroughly educated, and committed to long-term metabolic and functional follow-up to ensure the best possible outcomes.

Share this procedure: